Pharmaceutical Research and Manufacturers of America (Ph RMA)
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Trade_Federation
|
| gptkbp:advocates_for |
patient-centered care
public policies research transparency research and development funding patient access to medicines |
| gptkbp:collaborates_with |
healthcare stakeholders
|
| gptkbp:conducts |
policy analysis
public opinion research |
| gptkbp:engages_in |
public relations campaigns
community outreach programs lobbying activities stakeholder engagement activities |
| gptkbp:focus |
pharmaceutical research
|
| gptkbp:founded |
gptkb:1958
|
| gptkbp:has_a_website |
phrma.org
|
| gptkbp:has_mission |
advance medical innovation
|
| gptkbp:has_partnerships_with |
academic institutions
|
| gptkbp:has_role |
drug pricing discussions
drug approval processes |
| gptkbp:headquartered_in |
gptkb:the_United_States
|
| gptkbp:headquarters |
gptkb:Washington,_D._C.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Pharmaceutical Research and Manufacturers of America (Ph RMA)
|
| gptkbp:is_a_member_of |
the American Chamber of Commerce
the Pharmaceutical Research and Manufacturers of America Foundation |
| gptkbp:is_a_resource_for |
drug development
|
| gptkbp:is_a_source_of |
policy recommendations
information on drug innovation information on pharmaceuticals |
| gptkbp:is_involved_in |
legislative advocacy
global health initiatives healthcare access initiatives healthcare reform initiatives patient advocacy efforts health policy discussions drug affordability discussions healthcare technology assessments |
| gptkbp:is_led_by |
a president and CEO
|
| gptkbp:is_recognized_as |
a leader in pharmaceutical advocacy.
a leading voice in biopharmaceutical policy |
| gptkbp:is_recognized_for |
its contributions to public health
|
| gptkbp:members |
biopharmaceutical companies
|
| gptkbp:offers |
gptkb:educational_programs
networking opportunities |
| gptkbp:participated_in |
healthcare policy forums
|
| gptkbp:participates_in |
international trade discussions
|
| gptkbp:promotes |
innovation in drug development
|
| gptkbp:provides |
research funding
guidance on regulatory issues insights on market access data on drug development expertise on drug safety |
| gptkbp:publishes |
annual reports
|
| gptkbp:supports |
clinical trials
biomedical research healthcare innovation healthcare workforce development |
| gptkbp:was_a_proponent_of |
intellectual property rights
evidence-based medicine |
| gptkbp:works_with |
government agencies
|
| gptkbp:bfsParent |
gptkb:The_University_of_Iowa_College_of_Pharmacy
|
| gptkbp:bfsLayer |
6
|